Pneumococcal disease sounds technical, but it's essentially an infection caused by a bacterium called Streptococcus pneumoniae. This bacterium can cause several serious health problems, ranging from ear infections and sinus infections to much more severe conditions like pneumonia (lung infection), meningitis (brain and spinal cord infection), and bacteremia (bloodstream infection). Understanding what this disease is helps explain why doctors recommend vaccines against it.
Learn About Paying Your FGUA Bill Online →
The pneumococcus bacterium spreads through respiratory droplets—basically when someone coughs or sneezes. This is why pneumococcal disease tends to spread in places where people gather closely together, like daycare centers, schools, nursing homes, and military barracks. About 1 in 20 people carries pneumococcus in their nose and throat without getting sick, but they can still pass it to others.
According to the CDC, pneumococcal disease affects thousands of Americans each year. Before vaccines became available, pneumococcal pneumonia killed roughly one out of every 20 infected people, and meningitis from pneumococcus killed about one in four infected people. Certain groups face higher risk: children under 5 years old, adults 65 and older, people with chronic illnesses, and those with weakened immune systems.
Pneumococcal vaccines work by training your immune system to recognize and fight the pneumococcus bacterium before you actually encounter it. There are different pneumococcal vaccines available in the United States, each protecting against a different number of pneumococcal strains. Currently, the main vaccines used are PCV13 (Pneumovax 13), which protects against 13 strains, and PPSV23 (Pneumovax 23), which protects against 23 strains. Newer vaccines like PCV15 and PCV20 have expanded the number of strains covered.
Practical takeaway: Pneumococcal disease is preventable through vaccination. Knowing that this disease spreads through respiratory droplets and that vaccines can prevent serious infection is the foundation for understanding why vaccination schedules exist and why timing matters for different age groups.
Children in the United States follow a specific vaccination schedule for pneumococcal protection. The current recommendation includes four doses of a pneumococcal conjugate vaccine (PCV), given at specific ages to build immunity gradually. Most commonly, children receive doses at 2 months, 4 months, 6 months, and then a booster shot between 12 and 15 months of age.
Free Guide to Pay by Plate Illinois Billing →
The timing of these doses isn't random—each dose builds on the previous one. The first dose introduces the child's immune system to the vaccine. The second and third doses strengthen that immune response. The final booster dose, given after the child's first birthday, provides long-lasting protection. This four-dose series creates what doctors call "robust immunity," meaning the child's body has learned to recognize and fight pneumococcal infection effectively.
For children who miss doses or start their vaccinations late (after 2 months old), the schedule adjusts based on their age. A child who starts vaccination between 7 and 11 months old would still need four doses total, but the timing spreads out differently. A child starting between 12 and 23 months needs only three doses. A child starting at 2 years or older typically needs only two doses. These adjustments reflect how the immune system works—older children and adults don't need the same number of doses as infants because their immune systems are more mature.
In recent years, the CDC updated recommendations to include newer pneumococcal vaccines. Some children may receive PCV15 (which protects against 15 strains) or the newly approved PCV20 (which protects against 20 strains) instead of the traditional four-dose PCV13 series. PCV20, for example, can sometimes be given as a single dose for children 2 years and older, though this is still relatively new in the vaccination schedule.
Practical takeaway: Infants typically receive four pneumococcal vaccine doses between 2 months and 15 months of age. The exact number and timing of doses can change if a child starts vaccination later, and newer vaccines may offer different schedules with fewer doses. Parents should check with their child's healthcare provider about which vaccine their child will receive.
Adults aged 65 and older face a significantly higher risk of serious pneumococcal disease. As people age, their immune systems become less effective at fighting off infections, which is why older adults have higher hospitalization and death rates from pneumococcal disease compared to younger adults. The CDC reports that pneumococcal pneumonia causes thousands of hospitalizations among older Americans each year, with some estimates suggesting that people 65 and older account for more than half of all hospitalizations for pneumococcal pneumonia.
Free Guide to Mold Removal Methods for Walls →
The pneumococcal vaccination schedule for older adults has changed several times over recent years as new vaccines became available. Until recently, older adults typically received a dose of PCV13 followed by a dose of PPSV23. However, newer recommendations now focus on the newer vaccines PCV15 and PCV20. Many older adults aged 65 and up should receive a dose of PCV20, which provides protection against a wider range of pneumococcal strains than previous vaccines. Some older adults may instead receive PCV15 followed by PPSV23, depending on their health history and vaccination records.
For older adults who were previously vaccinated with PPSV23, the current recommendations may involve receiving one of the newer conjugate vaccines (PCV15 or PCV20). This doesn't mean previous vaccinations were wasted—it means adding additional protection by introducing the immune system to strains covered by the newer vaccines. The timing between vaccines matters: if someone received PPSV23 in the past, they typically need to wait at least one year before receiving a dose of PCV15 or PCV20.
Older adults with certain chronic conditions—like heart disease, lung disease, diabetes, or kidney disease—face even higher risk and should definitely discuss pneumococcal vaccination with their doctors. Additionally, adults who live in nursing homes or long-term care facilities, or those who live with family members, may have additional reasons to stay up to date on pneumococcal vaccines because pneumococcal disease spreads in congregate settings.
Practical takeaway: Adults 65 and older should talk with their healthcare provider about pneumococcal vaccination. The specific vaccine recommended may depend on age, previous vaccinations, and overall health. Newer vaccines like PCV20 offer broader protection than older vaccines, and the vaccination landscape for older adults has shifted significantly in recent years.
Beyond age 65, certain medical conditions significantly increase a person's risk of serious pneumococcal disease, making pneumococcal vaccination important at younger ages. Adults with chronic illnesses often have weakened or compromised immune systems, making it harder for their bodies to fight off infections. The CDC recommends pneumococcal vaccination for adults with specific medical conditions, even if they're younger than 65.
How to Delete Your Fitbit Account Guide →
Chronic heart disease represents one major risk factor. People with conditions like coronary artery disease, heart failure, or valve disease face higher risk of pneumococcal infection and its complications. Similarly, chronic lung disease—including asthma, COPD (chronic obstructive pulmonary disease), and emphysema—increases risk because the lungs are already compromised and more vulnerable to pneumococcal pneumonia. Diabetes, particularly when not well-controlled, also increases pneumococcal disease risk. People with diabetes have altered immune responses that make fighting off bacterial infections more difficult.
Chronic kidney disease, whether requiring dialysis or not, weakens the immune response and increases risk of serious infection. Liver disease, including cirrhosis, impairs the body's ability to fight off bacteria. People with functional or anatomic asplenia (a damaged or removed spleen) face dramatically increased risk because the spleen plays a crucial role in fighting pneumococcal bacteria. Additionally, adults with HIV or other conditions affecting immune function should be vaccinated according to their specific medical situation.
For these groups, the pneumococcal vaccination schedule may differ from standard older adult recommendations. Some adults with medical conditions may need doses of both
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.